Immunotherapy in Renal Failure

The emerging development in Immunotherapy brings new hope for the patients with refractory diseases. It makes it possible for the patients with Renal Failure avoid dialysis or kidney transplant.

Immunotherapy refers to infusion of healthy cells into the patients'body through intravenous injection. Immunotherapys are characterized by the ability to renew themselves through mitotic cells division and differentiating into a diverse range of specialized cell types. There two broad types of Immunotherapy including embryonic Immunotherapy and adult Immunotherapy that are found in adult tissues. For problems of ethics, the embryonic Immunotherapy are not applied in clinic. At present, adult Immunotherapy have been applied to treat diverse diseases.

In our hospital, the Immunotherapy are abstracted from umbilical cord blood of the new born baby. In the past, umbilical cord is considered as wastes. However, the present researches prove that umbilical cord blood is rich in Immunotherapy and are the most primitive Immunotherapy with immunological immaturity.
Therefore, after the Immunotherapy infused into body, they do not cause any adverse effects at all.

In treating Renal Failure, after the Immunotherapy regenerate them in vitro for several days, they will be infused into the patients'body. In right body condition, the Immunotherapy will differentiate into new renal functional cells to form tissues. The new cells will turn mature gradually in body to replace the diseased cells gradually. Finally, the kidneys will be restored very well. In clinic, the levels of creatinine, BUN etc will decline and the symptoms like nausea, anemia etc will relieve.


In our hospital, more than 1000 patients have received Immunotherapy and more than 85% of them have enormous improvement in renal function. If you want to know the successful case, it is free for you to consult us on line.